Skip to main content

Advertisement

Table 5 Correlation between metabolic phenotypes of stroma and clinicopathologic factors

From: Metabolic phenotypes in primary unknown metastatic carcinoma

Parameters Glycolysis type Glutaminolysis type Mitochondrial type
Yes No p-value Yes No p-value Yes No p-value
n = 2 (%) n = 75 (%)   n = 8 (%) n = 69 (%)   n = 74 (%) n = 3 (%)
Age    0.547    0.710    0.741
 <50 1 (50.0) 24 (32.0)   3 (37.5) 22 (31.9)   3 (25.0) 22 (33.8)  
 ≥50 1 (50.0) 51 (68.0)   5 (62.5) 47 (68.1)   9 (75.0) 43 (66.2)  
Sex    0.524    0.466    0.351
 Male 2 (100.0) 46 (61.3)   4 (50.0) 44 (63.8)   6 (50.0) 42 (64.6)  
 Female 0 (0.0) 29 (38.7)   4 (50.0) 25 (36.2)   6 (50.0) 23 (35.4)  
Clinical subtype    0.627    0.857    0.533
 Nodal type 1 (50.0) 33 (44.0)   3 (37.5) 31 (44.9)   5 (41.7) 29 (44.6)  
 Single organ type 1 (50.0) 14 (18.7)   1 (12.5) 14 (20.3)   4 (33.3) 11 (16.7)  
 Intermediate type 0 (0.0) 14 (18.7)   2 (25.0) 12 (17.4)   1 (8.3) 13 (20.0)  
 Carcinomatosis type 0 (0.0) 14 (18.7)   2 (25.0) 12 (17.4)   2 (16.7) 12 (18.5)  
Histologic type    0.050    0.237    0.049
 AD 0 (0.0) 27 (36.0)   5 (62.5) 22 (31.9)   8 (66.7) 19 (29.2)  
 PD 2 (100.0) 14 (18.7)   2 (25.0) 14 (20.3)   2 (16.7) 14 (21.5)  
 SQ 0 (0.0) 20 (26.7)   1 (12.5) 19 (27.5)   0 (0.0) 20 (30.8)  
 UP 0 (0.0) 14 (18.7)   0 (0.0) 14 (20.3)   2 (16.7) 12 (18.5)  
Organs involved    0.439    0.003    0.121
 Lymph node 1 (50.0) 48 (64.0)   4 (50.0) 45 (65.2)   6 (50.0) 43 (66.2)  
 Bone 1 (50.0) 9 (12.0)   0 (0.0) 10 (14.5)   3 (25.0) 7 (10.8)  
 Brain 0 (0.0) 9 (12.0)   0 (0.0) 9 (13.0)   0 (0.0) 9 (13.8)  
 Other 0 (0.0) 9 (12.0)   4 (50.0) 5 (7.2)   3 (25.0) 6 (9.2)  
  1. Bold represents p<0.05.